Central European Journal of Urology最新文献

{"title":"Renal and ureteral temperatures changes during ureteroscopic pulsed thulium: YAG laser lithotripsy: an <i>in vitro</i> analysis.","authors":"Felipe Urrea, José M Villena, Matias Larrañaga, José Antonio Salvadó","doi":"10.5173/ceju.2024.0177","DOIUrl":"https://doi.org/10.5173/ceju.2024.0177","url":null,"abstract":"<p><strong>Introduction: </strong>Promising studies have shown a high stone-free rate achieved with the pulsed solid-state thulium YAG laser. However, studies on its safety concerning temperature effects during activation remain limited. The aim of this study was to characterize temperature variations during laser activation.</p><p><strong>Material and methods: </strong>This <i>in vitro</i> experimental study utilized a high-fidelity uretero-renal simulation model to assess temperature changes during intracorporeal laser lithotripsy. Temperatures reached after laser activation at 15, 20, and 30 seconds were recorded. The flow rates used were 10 ml/min and 20 ml/min. The maximum allowed temperature was set at 43°C, given its association with thermal tissue damage. A linear logistic regression model was used to analyze variations and project temperature behavior over time.</p><p><strong>Results: </strong>In the renal model, temperature increases were correlated with the applied energy. With a 10 ml/min flow rate, no laser configuration exceeded 43°C at 15 seconds; at 20 seconds, only the 30 W (2.5 J/20 Hz) configuration exceeded this temperature. By 30 seconds, all 30 W configurations exceeded 43°C, except for 0.4 J/75 Hz. With a 20 ml/min flow rate, no laser configuration exceeded 43°C. The 20 ml/min flow rate decreased renal temperature by 1.96°C (p = 0.01). In the ureteral model, the temperature increase was not proportional to the applied energy, but in no scenario the temperatures reach the 43°C.</p><p><strong>Conclusions: </strong>The temperature variations observed in this study with the use of the pulsed solid-state thulium YAG laser should be considered to avoid potential renal and ureteral thermal damage.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 1","pages":"70-76"},"PeriodicalIF":1.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12073521/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reclassification of prostate cancer on first confirmatory prostate biopsy in men under active surveillance: A systematic review and meta-analysis.","authors":"Benjamin M Mac Curtain, Killian Daly, Gavin Calpin, Eoin Collins, Avinash Deshwal, Olwyn Lynch, Wanyang Qian, Aaron O'Mahony, Hugo C Temperley, Reuben D Mac Curtain, Diarmaid Moran, John A O Kelly, Catherine Dowling","doi":"10.5173/ceju.2025.0011","DOIUrl":"10.5173/ceju.2025.0011","url":null,"abstract":"<p><strong>Introduction: </strong>Prostate cancer is typically diagnosed following prostate biopsy. In low-risk and selected favourable intermediate-risk disease, active surveillance is the treatment strategy of choice. In these men, a confirmatory biopsy performed. We report on the rates of risk upgrading at biopsy confirmatory that may represent a need to pursue further treatment in lieu of active surveillance.</p><p><strong>Material and methods: </strong>We performed a systematic review and meta-analysis of pooled reclassification rates of men on active surveillance at first confirmatory biopsy, in line with PRISMA recommendations. PubMed, EMBASE, and Cochrane central registry for clinical trials were searched until June 2024. Stata was used to pool reclassification rates at first confirmatory biopsy.</p><p><strong>Results: </strong>Seventeen studies from 9 countries comprising 6,039 patients were included. Transrectal biopsy was the most common biopsy method for confirmatory biopsy. Weighted pooled rates of upgrading on first confirmatory biopsy were 20% with a 95% confidence interval of 19-21%.</p><p><strong>Conclusions: </strong>Approximately 20% of men undergoing active surveillance were upgraded at confirmatory biopsy. This may alter the management of these patients, and it highlights the importance of a confirmatory biopsy.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 2","pages":"125-136"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379824/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Single-J versus double-J stents after ureterorenoscopy for renal stones: A randomized comparison of safety and tolerability.","authors":"Catarina Laranjo Tinoco, Luis Martins, Francisca Costa, Andreia Cardoso, Ana Sofia Araújo, Mariana Capinha, Luis Pinto, Aparício Coutinho, Carlos Oliveira, Vera Marques, Joao Pimentel Torres, Paulo Mota","doi":"10.5173/ceju.2024.0212","DOIUrl":"10.5173/ceju.2024.0212","url":null,"abstract":"<p><strong>Introduction: </strong>Ureteral stents are generally used after ureterorenoscopy (URS) procedures, even in uncomplicated ones. We aimed to compare the safety and tolerability of single-J (SJ) stents and double-J (DJ) stents in patients submitted to flexible URS for renal stones.</p><p><strong>Material and methods: </strong>This prospective, randomized, unblinded, single-center study was conducted between July 2022 and May 2024, involving patients undergoing flexible URS with holmium laser lithotripsy for renal stones. Patients were randomized to either SJ stents (removed within 24 hours) or DJ stents (removed 2-4 weeks post-surgery). Primary endpoints included emergency department admissions, postoperative complications, and reintervention rates. Secondary endpoints included stent tolerability and surgery efficacy. A symptom questionnaire was applied at postoperative weeks 1 (W1) and 4 (W4).</p><p><strong>Results: </strong>We included 125 patients (60 in group SJ and 65 in group DJ), with comparable baseline characteristics. Emergency department admissions were similar (18.3% vs 16.9%, p = 0.84), as were complications (18.3% vs 21.5%, p = 0.65) and reintervention rates (1.7% vs 3.1%, p = 1.0). SJ stents showed better tolerability, with lower scores for lower urinary tract symptoms (LUTS) and pain at both time points.</p><p><strong>Conclusions: </strong>SJ stents placed for less than 24 hours after complete flexible URS are comparable to DJ stents regarding safety and are better tolerated, particularly 4 weeks after the surgery. SJ stents should be prioritized, reducing costs and hospital visits for stent removal.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 2","pages":"192-198"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Urinary incontinence as the first clinical symptom of urinary bladder leiomyosarcoma.","authors":"Łukasz Mazurczyk, Michał Czarnogórski, Aleksandra Czernicka, Paweł Lipowski, Adam Ostrowski, Kajetan Juszczak, Jan Adamowicz, Tomasz Drewa","doi":"10.5173/ceju.2024.0280","DOIUrl":"10.5173/ceju.2024.0280","url":null,"abstract":"<p><p>Urinary bladder leiomyosarcoma is an extremely rare malignancy of the urogenital system. We present the case of a 59-year-old Caucasian male with a gigantic bladder leiomyosarcoma. The patient was subdued to the surgical excision of the urinary bladder - laparoscopic radical cystectomy with extended pelvic lymphadenectomy, with urinary diversion by bilateral ureterocutaneostomy. The excision was complete both macroscopically and microscopically. No additional adjuvant therapy was administered. In the 6-month follow-up, the patient remained in radiological remission. Surgical excision with extended pelvic lymphadenectomy seems to be sufficient in the treatment of urinary bladder leiomyosarcoma.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 2","pages":"103-108"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Ureteral stents with extraction strings - a review on infection risk and prevention.","authors":"Patryk Osiński, Jakub Bartłomiej Kawecki, Martyna Zofia Stachoń, Izabela Teresa Zawadzka, Ewa Bres-Niewada, Bartosz Dybowski","doi":"10.5173/ceju.2024.0222","DOIUrl":"https://doi.org/10.5173/ceju.2024.0222","url":null,"abstract":"<p><strong>Introduction: </strong>This review aims to determine whether the use of ureteral stents with extraction strings in adult patients undergoing upper urinary tract endoscopic procedures results in a higher incidence of urinary tract infections (UTIs) compared to stents without strings.</p><p><strong>Material and methods: </strong>A systematic literature search was conducted using PubMed, Scopus, and Google Scholar. Studies evaluating differences in UTI rates among adult patients with ureteral stents with or without extraction strings were included. Data on UTI rates, antibiotic prophylaxis protocols, and stent dwell time were extracted.</p><p><strong>Results: </strong>The review included 11 trials published between 2015 and 2023. One multicenter retrospective study involving 4,392 patients reported a significantly higher UTI rate in patients with extraction strings (2.1% vs 1.1%, p = 0.006). In the remaining 10 studies, including four randomized controlled trials, the differences were not statistically significant. Antibiotic prophylaxis was described in five studies. In two studies, a single perioperative antibiotic dose was administered, with a total UTI rate of 6.8% (28/410). In contrast, three studies using prolonged prophylactic antibiotic regimens reported a total UTI rate of 3.2% (13/403). The impact of stent dwell time on UTI risk could not be determined. The risk of bias was high in 10 studies and moderate in one retrospective study.</p><p><strong>Conclusions: </strong>Based on low-quality evidence, the difference in UTI risk between ureteral stents with and without extraction strings appears to be minimal and statistically insignificant. Well-designed studies with standardized methodologies are needed to clarify these findings.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 1","pages":"94-99"},"PeriodicalIF":1.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12073513/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Influence of pre-stenting on flexible and navigable suction (FANS) access sheath outcomes. Results of a prospective multicentre study by the EAU Section of Endourology and the global FANS collaborative group.","authors":"Victoria Jahrreiss, Vineet Gauhar, Olivier Traxer, Khi Yung Fong, Saeed Bin Hamri, Karl Tan, Vigen Malkhasyan, Satyendra Persaud, Mohamed Elshazly, Wissam Kamal, Steffi Yuen, Vikram Sridharan, Daniele Castellani, Mehmet Ilker Gökce, Nariman Gadzhiev, Deepak Ragoori, Boyke Soebhali, Chu Ann Chai, Azimdjon N Tursunkulov, Yiloren Tanidir, Tzevat Tefik, Anil Shrestha, Marek Zawadzki, Mohamed Amine Lakmichi, Christian Seitz, Bhaskar K Somani","doi":"10.5173/ceju.2024.0197","DOIUrl":"https://doi.org/10.5173/ceju.2024.0197","url":null,"abstract":"<p><strong>Introduction: </strong>Pre-stenting remains a subject of debate, and its influence on FANS assisted ureteroscopy is unclear. The global FANS collaborative group aims to address the influence of pre-stenting on FANS-assisted ureterorenoscopy (URS).</p><p><strong>Material and methods: </strong>This prospective multicentre study assesses the outcomes of 394 patients undergoing FANS-assisted ureteroscopy for renal stones. Patients were stratified into a non-pre-stented (group 1, n = 163) and pre-stented group (group 2, n = 231). Data on demographics, stone characteristics, operative parameters, and postoperative 30-day outcomes were analysed. Statistical analyses, including multivariate regression, were performed for stone-free rates (SFR) and complications. SFR was defined by bone window on non-contrast computed tomography (CT).</p><p><strong>Results: </strong>Pre-stented patients had a higher prevalence of positive urine culture treated with preoperative antibiotics (23.8% vs 12.3%, p = 0.006). Larger stone volumes were noted (1,306 mm³ vs 1,200 mm³, p = 0.027) in group 1. Postoperative complications were minor. Sepsis was not reported in either group. Group 1 had a higher incidence of low-grade Traxer grade 1 ureteric injuries (4.3% vs 0.4%, p = 0.021). FANS resulted in high overall SFRs of 97.5% and 97.0% in groups 1 and group 2. Multivariate analysis showed no statistical difference in SFR between the groups (63.2% vs 53.2%, p = 0.063). Only thulium fibre laser (TFL) and stone volume were significant predictors of residual fragments (RF).</p><p><strong>Conclusions: </strong>Pre-stenting for FANS is not mandatory irrespective of stone location and volume. The use of TFL and stone volume significantly influenced SFR, while FANS itself proved highly effective in achieving high SFR.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 1","pages":"85-93"},"PeriodicalIF":1.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12073519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of Rezum water vapor therapy for benign prostate obstruction with 1-year follow-up: Largest real-world data from Turkey.","authors":"Basri Cakiroglu, İsmail Cenk Acar, Bekir Sami Uyanık","doi":"10.5173/ceju.2024.0224","DOIUrl":"10.5173/ceju.2024.0224","url":null,"abstract":"<p><strong>Introduction: </strong>The study aimed to retrospectively assess the safety and efficacy of Rezum, a promising minimally invasive treatment method for BPH, in patients treated at our clinic.</p><p><strong>Material and methods: </strong>From January 1, 2022, to December 31, 2022, a cohort of 71 patients presenting with moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) were enrolled in the study. These individuals opted for Rezum therapy as their treatment approach. Primary outcome measures included the International Prostate Symptom Score (IPSS), maximum flow rate (Q_max), post-void residual volume (PVR), Quality of Life (QoL), prostate volume (PV), prostate-specific antigen (PSA), and the International Index of Erectile Function (IIEF) questionnaire.</p><p><strong>Results: </strong>The median age of the 71 patients was 62.1 ±9.3 years, with a median PV of 60.4 ±16.6 ml. Preoperatively, IPSS was 21.9 ±5.2, Q_max was 9.67 ±3.2, QoL was 3.35 ±0.61, IIEF-5 was 23.9 ±5.4, total PSA was 2.43 ±1.27 ng/ml, and PVR was 177.4 ±216.5 ml. At the 3-month follow-up, IPSS improved to 10.1 ±5.6, Q_max to 24.5 ±3.7, QoL to 1.2±0.51, IIEF-5 to 24.5 ±5.4, total PSA to 1.8 ±0.9 ng/ml, and PVR remained at 177.4 ±216.5 ml. At the 12-month follow-up, IPSS was 6.0 ±3.1, Q_max was 18.12 ±3.7, QoL was 1.2 ±0.51, IIEF-5 was 24.5 ±5.4, total PSA was 1.8 ±0.9 ng/ml, and PVR was 24.9 ±25.2 ml.</p><p><strong>Conclusions: </strong>Rezum therapy is a safe, effective, and minimally invasive option for the treatment of men with moderate to severe lower urinary tract symptoms (LUTS).</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 2","pages":"144-150"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Robotic retrocaval ureter repair.","authors":"Maxwell Sandberg, Randall Bissette, Ashok Hemal","doi":"10.5173/ceju.2024.0251","DOIUrl":"https://doi.org/10.5173/ceju.2024.0251","url":null,"abstract":"","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 1","pages":"102"},"PeriodicalIF":1.4,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12073510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144074959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Complications of anatomical endoscopic enucleation of the prostate in real-life practice: What we learnt from the 6,193 patients from the Refinement in Endoscopic Anatomical enucleation of Prostate registry.","authors":"Ee Jean Lim, Thomas R W Herrmann, Daniele Castellani, Khi Yung Fong, Edwin Jonathan Aslim, Sarvajit Biligere, Azimdjon N Tursunkulov, Marco Dellabella, Fernando Gomez Sancha, Mario Sofer, Dmitry Enikeev, Marcelo Langer Wroclawski, Vladislav Petov, Nariman Gadzhiev, Dean Elterman, Abhay Mahajan, Moises Rodriguez Socarras, Dilmurod S Yunusov, Furkat Nasirov, Jeremy Yuen-Chun Teoh, Bhaskar Kumar Somani, Vineet Gauhar","doi":"10.5173/ceju.2024.0060","DOIUrl":"10.5173/ceju.2024.0060","url":null,"abstract":"<p><strong>Introduction: </strong>Anatomical endoscopic enucleation of the prostate (AEEP) is a guideline-recommended treatment for benign prostatic hyperplasia (BPH). We aimed to analyze postoperative complications and outcomes within a large real-world database.</p><p><strong>Material and methods: </strong>The Refinement in Endoscopic Anatomical enucleation of Prostate (REAP) registry includes patients who received AEEP for BPH in 8 centers worldwide from January 2020 to January 2022. Exclusion criteria included previous prostate/urethral surgery, prostate cancer, pelvic radiotherapy, and concomitant lower urinary tract surgery (internal urethrotomy, cystolithotripsy, or transurethral resection of bladder tumor). The primary outcome was postoperative incontinence; secondary outcomes included early complications (<30 days) and late complications (>30 days).</p><p><strong>Results: </strong>We analyzed 6,193 patients; the mean age was 68 years. Thulium laser was used in 37% and high-power holmium laser in 32%. Median operation time was 67 min [IQR 50-95 min]. The 2-lobe enucleation technique was utilized in 49%, and en-bloc resection was utilized in 39%. Early postoperative complications included urinary tract infection (4.7%), acute urinary retention (4.1%), post-operative bleeding requiring additional intervention (0.9%), and sepsis requiring intensive care admission (0.1%). The incidence of postoperative incontinence was 14.8%, of which 54% were stress incontinence; 84% cases resolved by 3 months. On univariate and multivariate analysis, prostate volume >100 ml was a significant predictor of postoperative incontinence. Late complications such as bulbar urethral stricture, bladder neck sclerosis, and need for redo BPH surgery each occurred in <1% of patients.</p><p><strong>Conclusions: </strong>Analysis of the real-world REAP database shows favorable safety outcomes for AEEP, with a low incidence of serious complications and postoperative incontinence beyond 3 months.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 2","pages":"137-143"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Balancing technology and resources: Is robotic pyeloplasty always necessary?","authors":"Kunal Malhotra, Vikas Kumar Panwar, Gautam Shubhankar, Ankur Mittal, Mohammed Taher Mujahid","doi":"10.5173/ceju.2024.0203","DOIUrl":"10.5173/ceju.2024.0203","url":null,"abstract":"<p><strong>Introduction: </strong>Ureteropelvic junction obstruction (UPJO) hinders urine flow from the renal pelvis to the ureter, causing renal dysfunction. Treatment focuses on relieving obstruction to restore urinary drainage and preserve renal function. Robotic-assisted laparoscopic pyeloplasty (RALP) offers enhanced precision compared to laparoscopic pyeloplasty (LP), but limited comparative data exist for adult patients. This study compares RALP and LP outcomes in an adult cohort from a tertiary care centre.</p><p><strong>Material and methods: </strong>A retrospective cohort analysis was conducted on adult patients who underwent RALP or LP between March 2018 and May 2024. Primary outcome measures included operative time, with secondary outcomes such as estimated blood loss (EBL), hospital length of stay (LOS), complication rates, and success (defined by symptom relief and diuretic renogram improvement). Statistical analysis included Mann-Whitney, χ², and Fisher's exact tests, with a significance threshold of p <0.05.</p><p><strong>Results: </strong>The study included 128 patients (87 RALP, 41 LP). Operative time was significantly longer for RALP (200.92 ±59.26 minutes) vs LP (161.92 ±55.21 minutes, p <0.001), largely due to robotic docking. Both groups had similar EBL (47.87 ml for RALP vs 45 ml for LP, p = 0.45) and success rates (97.7% for RALP vs 97.4% for LP). However, RALP patients experienced a longer LOS (3.91 days vs 3.41 days, p = 0.001).</p><p><strong>Conclusions: </strong>RALP demonstrates technical advantages but does not reduce operative time and incurs increased resource utilisation compared to LP. Both techniques achieve high success rates, though further research is needed to assess RALP's cost-effectiveness.</p>","PeriodicalId":9744,"journal":{"name":"Central European Journal of Urology","volume":"78 2","pages":"244-249"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144944300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}